| Literature DB >> 29904657 |
Anu S Helin1, Michelle Wille1, Clara Atterby2, Josef Järhult3, Jonas Waldenström1, Joanne R Chapman1,4.
Abstract
This article provides data on primer sequences used to amplify the innate immune genes RIG-I and Mx and a set of normalizing reference genes in mallards (Anas platyrhynchos), and shows which reference genes are stable, per tissue, for our experimental settings. Data on the expressional changes of these two genes over a time-course of infection with low pathogenic avian influenza virus (LPAI) are provided. Individual-level data are also presented, including LPAI infection load, and per tissue gene expression of RIG-I and Mx. Gene expression in two outlier individuals is explored in more depth.Entities:
Year: 2018 PMID: 29904657 PMCID: PMC5998173 DOI: 10.1016/j.dib.2018.04.061
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Previous studies of RIG-I and Mx gene expression in mallard and Pekin ducks infected with AIV. Only studies using quantitative real-time PCR to assess patterns of gene expression are included. Only results significantly different from controls are listed, and all fold-changes represent upregulation compared to controls (no study found down-regulation of either gene at any time point). EID50 is 50% egg infectious dose, MOI is multiplicity of infection, PFU is plaque forming units, RGs is reference genes, dpi is days post infection, hpi is hours post infection, N indivs is number of individuals per time point, wk is week.
| HPAI | H5N1 | 106 of EID50 | Dripped into nares, eyes & trachea | Lung, intestine | 1, 3 dpi | 3 | Pekin | Lung: ~200-fold at 1dpi, ~20-fold at 3 dpi | |||
| Intestine: ~5-fold at 1dpi, ~2.5-fold at 3 dpi | |||||||||||
| LPAI | H5N2 | 106 of EID50 | Dripped into nares, eyes & trachea | Lung, intestine | 1, 3 dpi | 2-3 | Pekin | No significant changes | |||
| HPAI | H5N1 | 105 of EID50 | Intranasal | Spleen | 2 dpi | 4 | Pekin | 13-fold | |||
| LPAI | H7N1 | 2 × 105 of EID50 | Dripped intranasally & intratracheally | Lung, bursa, ileum | 0.8, 2, 4, 7, 14 dpi | 6 | Pekin | ~7-17-fold at 0.8 dpi in all 3 tissues | |||
| HPAI | H7N1 | 2 × 105 of EID50 | Dripped intranasally & intratracheally | Lung, brain, spleen | 0.3, 1, 2, 3, 4, 5, 7 dpi | 6 | Pekin | Spleen: ~10-fold at 1&2 dpi, 2-4-fold at 3&4 dpi | |||
| Brain: ~1.8-fold at 2 dpi | |||||||||||
| Lung: ~6-8-fold at 1,2&3 dpi, ~2-fold at 4 dpi | |||||||||||
| HPAI | H5N1 | 105 of EID50 | Intranasal | Spleen, lung | 2 dpi | 4 | Pekin | Spleen: ~65-fold in 5wk old ducks, ~4-fold in 2wk old ducks | |||
| Lung: ~7-fold in 5wk old ducks, ~2.5-fold in 2wk old ducks | |||||||||||
| LPAI | recombinant | 0.1 MOI | Cells & virus mixed together | Embryo fibroblast cells | 2, 4, 8, 12, 24 hpi | NA | Pekin | ~500-1000-fold at 8-24 hpi | |||
| HPAI | H5N1 | 1.0 MOI | Cells & virus mixed together | Peripheral blood mononuclear cells | 4, 8, 12, 24, 36, 48 hpi | NA | Mallard | 25-40-fold at 8-24 hpi | |||
| LPAI | H1N1 | 0.1 MOI | Cells & virus mixed together | Primary lung cells | 12, 24, 48 hpi | NA | Pekin | No significant changes | |||
| LPAI | H5N9 | 0.1 MOI | Cells & virus mixed together | Primary lung cells | 12, 24, 48 hpi | NA | Pekin | ~5-fold at 12 hpi, 12-fold at 24 hpi, ~8-fold at 48 hpi | |||
| LPAI | H7N1 | 107 PFU | Intrachoanal cleft & oral | Illeum | 1, 6 dpi | 6-7 | Pekin | Upregulation at 1 & 6 dpi | |||
| LPAI | H7N1 | 107 PFU | Intrachoanal cleft & oral | Illeum | 1, 6 dpi | 3 | Pekin | Upregulation at 1 & 6 dpi |
Three strains, derived from chicken, egret and duck.
Authors state β-actin was stable between uninfected and infected, but no details given and no other RGs investigated.
Authors state that 18S had the most stable expression over time and between tissues in ducks, but data is not shown and no indication of which RGs were compared.
Five control individuals.
Many results were inferred from graphs because exact results were not listed. In such cases, ~ is used to indicate fold changes are approximate.
Results not expressed as fold-change. Significant upregulation with one of the two tested viruses only.
Reference genes used for each tissue type, and the number of samples available per time point per tissue.
| Blood | RPS13, UBE20, RPL4 | 5 | 5 | 5 | 5 | 5 | 5 |
| Spleen | RPS13, SDHA, GAPDH | 5 | 5 | 5 | 5 | 5 | 5 |
| GI1 | RPS13, RPL4 | 4 | 4 | 4 | 4 | 5 | 4 |
| GI2 | RPL4, RPL30 | 4 | 3 | 4 | 5 | 5 | 4 |
| Colon | RPL4, SDHA | 5 | 4 | 3 | 4 | 5 | 3 |
Primers used in [1]. F denotes the forward primer and R the reverse primer. Annealing temperature (Ta) expressed in °C and length in base pairs (bp).
| Retinoic acid-inducible gene-I | F | GTGTATGGAGGAAAACCCTATTCTTAACT | 59 | 95 | |
| R | GGAGGGGTGATACCTGTTGTTTGAT | ||||
| Myxovirus resistance | F | TTCATGACTTCGGCGACAAC | 59 | 128 | |
| R | AACTCGGCCACTGAGGTAAT | ||||
| Glyceraldehyde-3-phosphate dehydrogenase | F | GGTTGTCTCCTGCGACTTCA | 60 | 164 | |
| R | TCCTTGGATGCCATGTGGAC | ||||
| Ribosomal protein L4 | F | CCTGGGCCTTAGCTGTAACC | 60 | 115 | |
| R | AAGCTGAACCCATACGCCAA | ||||
| Ribosomal protein L30 | F | CTCAATGTTGTTGCCGCTGT | 60 | 119 | |
| R | GCAAAGCCAAGCTGGTCATC | ||||
| Ribosomal protein S13 | F | AAGAAAGGCCTGACTCCCTC | 59 | 82 | |
| R | TGCCAGTAACAAAGCGAACC | ||||
| Succinate dehydrogenase complex, subunit A | F | GACACAGTGAAAGGCTCCGA | 60 | 90 | |
| R | CTCCAGCTCTATCACGGCAG | ||||
| Ubiquitin-conjugating enzyme E2O | F | AGCATCCCCCTTTCCATCAA | 59 | 91 | |
| R | CAACCCTGTCTCCTGGCTTA |
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |